Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 90601-90650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05215665
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
NA
Recruiting
146 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2026
1 condition
1 sponsor
1 location
NCT06727981
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
N/A
Recruiting
500 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2028
2 conditions
1 sponsor
1 location
NCT05266196
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
PHASE1/PHASE2
Enrolling by invitation
10 participants
Started: Jan 15, 2022 · Completed: Dec 31, 2025
9 conditions
1 sponsor
1 location
NCT05257785
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
NA
Recruiting
50 participants
Started: Jan 15, 2022 · Completed: Dec 1, 2024
2 conditions
3 sponsors
1 location
NCT05176015
Nystagmus Assessment for Patients Consulting in the Emergency Department for Acute Vertigo
NA
Active, not recruiting
120 participants
Started: Jan 15, 2022 · Completed: Oct 31, 2024
2 conditions
1 sponsor
5 locations
NCT05728931
New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes
N/A
Active, not recruiting
210 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2032
2 conditions
1 sponsor
1 location
NCT05554003
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
PHASE2
Recruiting
46 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04981145
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
PHASE4
Recruiting
78 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05192798
Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
PHASE2
Recruiting
128 participants
Started: Jan 14, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT05061030
Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents
PHASE1/PHASE2
Recruiting
66 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05176769
Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI)
N/A
Recruiting
60,000 participants
Started: Jan 14, 2022 · Completed: Mar 1, 2026
3 conditions
8 sponsors
9 locations
NCT05215353
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
PHASE4
Recruiting
350 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
3 locations
NCT06108466
RELIABILITY AND VALIDITY OF THE DT BALANCE TEST IN PATIENTS WITH TKA
N/A
Active, not recruiting
31 participants
Started: Jan 14, 2022 · Completed: Nov 25, 2023
2 conditions
1 sponsor
1 location
NCT05043051
Autoimmune Basis for Postural Tachycardia Syndrome
NA
Recruiting
80 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04999423
LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
N/A
Active, not recruiting
206 participants
Started: Jan 14, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
19 locations
NCT05152472
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
PHASE2
Recruiting
110 participants
Started: Jan 14, 2022 · Completed: Oct 31, 2027
3 conditions
1 sponsor
12 locations
NCT05188508
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
PHASE2
Recruiting
57 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
10 locations
NCT06773065
Central Awareness in Women With Endometriosis
N/A
Recruiting
310 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT05067634
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
PHASE3
Recruiting
140 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
55 locations
NCT05190172
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
NA
Recruiting
225 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2043
3 conditions
13 sponsors
1 location
NCT05851014
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
PHASE3
Recruiting
350 participants
Started: Jan 14, 2022 · Completed: Jan 30, 2027
1 condition
1 sponsor
52 locations
NCT05243082
Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
NA
Recruiting
20 participants
Started: Jan 14, 2022 · Completed: Nov 11, 2029
1 condition
4 sponsors
1 location
NCT05127954
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
PHASE3
Enrolling by invitation
1,200 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2028
1 condition
1 sponsor
113 locations
NCT05154994
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
PHASE1
Recruiting
9 participants
Started: Jan 14, 2022 · Completed: Nov 30, 2027
4 conditions
2 sponsors
1 location
NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
PHASE2/PHASE3
Recruiting
290 participants
Started: Jan 14, 2022 · Completed: Sep 24, 2027
2 conditions
1 sponsor
113 locations
NCT05170867
The Impact of Hafnia Alvei on Weight Loss and Glycaemic Control After Bariatric Surgery
NA
Active, not recruiting
49 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05197920
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
N/A
Recruiting
800 participants
Started: Jan 14, 2022 · Completed: Jun 30, 2030
1 condition
15 sponsors
13 locations
NCT05187312
Registry for Advanced Endoscopy
N/A
Recruiting
1,000 participants
Started: Jan 14, 2022 · Completed: Jan 14, 2032
3 conditions
2 sponsors
1 location
NCT05206890
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
N/A
Recruiting
490 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2032
1 condition
15 sponsors
1 location
NCT05106322
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
N/A
Recruiting
240 participants
Started: Jan 14, 2022 · Completed: Nov 14, 2024
1 condition
1 sponsor
3 locations
NCT05149664
A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD
NA
Active, not recruiting
12 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT04937166
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
PHASE1
Active, not recruiting
36 participants
Started: Jan 13, 2022 · Completed: Jun 30, 2025
3 conditions
1 sponsor
2 locations
NCT04521699
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
NA
Recruiting
100 participants
Started: Jan 13, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT04821310
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
PHASE2
Active, not recruiting
110 participants
Started: Jan 13, 2022 · Completed: May 9, 2030
1 condition
1 sponsor
26 locations
NCT05160597
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Jan 13, 2022 · Completed: Jan 7, 2027
1 condition
1 sponsor
1 location
NCT05407636
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
PHASE3
Recruiting
660 participants
Started: Jan 13, 2022 · Completed: Nov 30, 2027
6 conditions
2 sponsors
181 locations
NCT04873050
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
PHASE4
Recruiting
102 participants
Started: Jan 13, 2022 · Completed: Mar 1, 2026
2 conditions
2 sponsors
1 location
NCT05157698
Pharmacological and Behavioral Treatment After Bariatric Surgery
PHASE2/PHASE3
Recruiting
160 participants
Started: Jan 13, 2022 · Completed: Jan 12, 2028
1 condition
2 sponsors
1 location
NCT05027685
"The Global Paradise System Registry"
N/A
Recruiting
3,000 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2031
1 condition
1 sponsor
35 locations
NCT05045612
Antibiotic Therapy in Viral Airway Infections
PHASE4
Recruiting
380 participants
Started: Jan 13, 2022 · Completed: Nov 30, 2029
4 conditions
2 sponsors
12 locations
NCT05020080
Operant Conditioning for Rehabilitation After Stroke
NA
Recruiting
20 participants
Started: Jan 13, 2022 · Completed: Jul 12, 2024
1 condition
2 sponsors
1 location
NCT05228964
Focused Ultrasound Amygdala Neuromodulation
NA
Active, not recruiting
20 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT05117840
Screening for High Frequency Malignant Disease
N/A
Active, not recruiting
12,000 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
143 locations
NCT05307120
Lifestyle Monitoring and Coaching Using the Mobile DIAMETER Application in Secondary Care
NA
Recruiting
80 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05252351
Cardiac Imaging in Adults With Congenital Aortic Stenosis
N/A
Active, not recruiting
75 participants
Started: Jan 13, 2022 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
NCT05184361
Effects of Intermittent Versus Continuous Energy Restriction on Metabolic Adaptation in Women With Obesity
NA
Active, not recruiting
74 participants
Started: Jan 13, 2022 · Completed: Jun 30, 2024
2 conditions
2 sponsors
1 location
NCT06324565
Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion
N/A
Recruiting
130 participants
Started: Jan 13, 2022 · Completed: Dec 13, 2024
1 condition
1 sponsor
9 locations
NCT05218785
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
N/A
Recruiting
40 participants
Started: Jan 13, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT05799339
Optimizing CAB-LA as PrEP for Women Who Inject Drugs
N/A
Active, not recruiting
144 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2025
3 conditions
5 sponsors
1 location
NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
PHASE3
Recruiting
1,059 participants
Started: Jan 13, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
118 locations
Previous
1
More pages
1810
1811
1812
1813
1814
1815
1816
More pages
2369
Next